Myriad Genetics Inc. Common Stock [MYGN]
The TickerPaging button is a members-only feature. (Million)
Annual Financial Data
Date | Revenue | NetIncome | Operating CF | Assets | Equity |
---|
2018/06 | 772.6 | 131.1 | 115.9 | 1,174.1 | 964.9 |
2019/06 | 851.1 | 4.6 | 83.7 | 1,562.7 | 1,088.9 |
2020/06 | 638.6 | -199.5 | 60.7 | 1,404.6 | 918.2 |
2021/12 | 690.6 | -27.2 | 18.2 | 1,320.7 | 967.8 |
Annual Indicators
Date | Stock Price | BPS | PBR | EPS(Annual) | PER(Annual) |
---|
2018/06 | 37.37 | 13.67 | 2.73 | 1.82 | 20.53 |
2019/06 | 27.78 | 14.81 | 1.88 | 0.06 | 463.00 |
2020/06 | 11.34 | 12.29 | 0.92 | -2.69 | minus |
2021/12 | 27.60 | 12.10 | 2.28 | -0.35 | minus |
Quarterly PL/CFS/BS
Date | Revenue | NetIncome | Operating CF | Operating CF Margin | Equity |
---|
2017/12 | 194 | 32.1 | 33 | 17.0% | 914.2 |
2018/03 | 193.5 | 11.4 | 11.5 | 5.9% | 948.3 |
2018/06 | 200.9 | 13.1 | 47.9 | 23.8% | 964.9 |
2018/09 | 202.3 | -0.7 | 7.8 | 3.9% | 1,102.2 |
2018/12 | 216.8 | 2.6 | 37.8 | 17.4% | 1,064.2 |
2019/03 | 216.6 | 6.9 | 6.6 | 3.0% | 1,081.8 |
2019/06 | 215.4 | -4.2 | 31.5 | 14.6% | 1,088.9 |
2019/09 | 186.3 | -20.6 | 15.8 | 8.5% | 1,074.5 |
2019/12 | 195.1 | -8.3 | -1.9 | --% | 1,077.2 |
2020/03 | 164 | -115.2 | 16.8 | 10.2% | 967.2 |
2020/06 | 93.2 | -55.4 | 30 | 32.2% | 918.2 |
2020/09 | 145.2 | -15.2 | -59.3 | --% | 909.3 |
2021/03 | 173.1 | -39.5 | 71.8 | 41.5% | 875.2 |
2021/06 | 189.4 | -4.7 | -4.4 | --% | 902.5 |
2021/09 | 167.3 | 24.6 | -39.3 | --% | 968.6 |
2021/12 | 160.8 | -7.6 | -9.9 | --% | 967.8 |
2022/03 | 164.9 | -20.5 | -46.5 | --% | 950.1 |
2022/06 | 179.3 | -14.1 | -50.3 | --% | 947.4 |
2022/09 | 156.4 | -35.1 | -1.8 | --% | 916.6 |
Quarterly Indicators
Date | Stock Price | BPS | PBR | EPS(Quarterly) | PER(Annual conversion) | Outstanding Stocks |
---|
2017/12 | 34.35 | 13.17 | 2.61 | 0.45 | 19.08 | 69.4 |
2018/03 | 29.55 | 13.57 | 2.18 | 0.16 | 46.17 | 69.9 |
2018/06 | 37.37 | 13.67 | 2.73 | 0.18 | 51.90 | 70.6 |
2018/09 | 46.00 | 14.76 | 3.12 | -0.01 | minus | 74.7 |
2018/12 | 29.07 | 14.54 | 2.00 | 0.03 | 242.25 | 73.2 |
2019/03 | 33.20 | 14.74 | 2.25 | 0.09 | 92.22 | 73.4 |
2019/06 | 27.78 | 14.81 | 1.88 | -0.06 | minus | 73.5 |
2019/09 | 28.63 | 14.44 | 1.98 | -0.28 | minus | 74.4 |
2019/12 | 27.23 | 14.46 | 1.88 | -0.11 | minus | 74.5 |
2020/03 | 14.31 | 12.98 | 1.10 | -1.55 | minus | 74.5 |
2020/06 | 11.34 | 12.29 | 0.92 | -0.74 | minus | 74.7 |
2020/09 | 13.04 | 12.09 | 1.08 | -0.20 | minus | 75.2 |
2021/03 | 30.45 | 11.41 | 2.67 | -0.52 | minus | 76.7 |
2021/06 | 30.58 | 11.62 | 2.63 | -0.06 | minus | 77.7 |
2021/09 | 32.29 | 12.15 | 2.66 | 0.30 | 26.91 | 79.7 |
2021/12 | 27.60 | 12.10 | 2.28 | -0.10 | minus | 80 |
2022/03 | 25.20 | 11.83 | 2.13 | -0.26 | minus | 80.3 |
2022/06 | 18.17 | 11.75 | 1.55 | -0.18 | minus | 80.6 |
2022/09 | 19.08 | 11.33 | 1.68 | -0.43 | minus | 80.9 |
About The Unit
- Revenue,NetIncome,Operating CashFlow,Assets,StockHolder's Equity : Million Dollars
- StockPrice,BPS,EPS,DPS : One USD
- Outstanding Stocks : Million Stocks
- PPBR,PER: Integer multiple